Hypertension and stroke;Folgen der Hypertonie am Endorgan Gehirn

Internist

Volumn 44, Issue 7, 2003, Pages 786-792

  Diener, H C ^a   Philipp, Th ^b   Schrader, J ^b  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b NONE

Author keywords

Blood pressure; Hypertension; Primary prevention; Secondary prevention; Stroke

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANTIHYPERTENSIVE AGENT; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CAPTOPRIL; CLONIDINE; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FELODIPINE; GLYCERYL TRINITRATE; HYDRALAZINE; LOSARTAN; METOPROLOL; NICARDIPINE; NIFEDIPINE; NITROPRUSSIDE SODIUM; PERINDOPRIL; THIAZIDE DIURETIC AGENT; URAPIDIL; VERAPAMIL;

ANTIHYPERTENSIVE THERAPY; BLOOD PRESSURE REGULATION; DRUG EFFICACY; HUMAN; HYPERTENSION; MULTIINFARCT DEMENTIA; PATHOPHYSIOLOGY; PRIMARY PREVENTION; REVIEW; RISK FACTOR; SECONDARY PREVENTION; STROKE; TRANSIENT ISCHEMIC ATTACK;

ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CEREBROVASCULAR ACCIDENT; HUMANS; HYPERTENSION; RECEPTORS, SENSORY; RISK FACTORS; TREATMENT OUTCOME;

EID: 0037702132     PISSN: 00209554     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00108-003-0937-1     Document Type: Review

References (33)

1. Broderick J, Brott T, Barsan W et al. (1993) Blood pressure during the first minutes of focal cerebral ischemia. Ann Emerg Med 22: 1438-1443
2. Brown MJ, Palmer CR, Castaigne A et al. (2000) Morbidity and mortality in patients randomised in double-blind treatment with a long-acting calcium-channel blocker or diuretic in the international nifedipine GIT5 study: intervention as a goal in hypertension treatment (INSIGHT). Lancet 356: 366-372
3. Carlberg B, Asplund K, Hägg E (1993) The prognostic value of admission blood pressure in patients with acute stroke. Stroke 24: 1372-1375
4. Dahlof B, Devereux RB, Kjeldsen SE, et al. and the LIFE Study Group (2002) Cardiovascular morbidity and mortality in the Losartan intervention for endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet 359: 995-1003
5. Grau AJ, Weimar C, Buggle F et al. (2001) Risk factors, outcome, and treatment in subtypes of ischemic stroke: the German stroke data bank. Stroke 32: 2559-2566
6. Gueyffler F, Bulpitt C, Boissel JP et al. for the INDANA Group (1999) Antihypertensive drugs in very old people: a subgroup meta-analysis of randomised controlled trials. Lancet 353: 793-796
7. Hansson L, Hedner T, Lund-Johansen P et al. for the NORDIL study group (2000) Randomised trial of effects of calcium antagonists compared with diuretics and beta-blockers on cardiovascular morbidity and mortality in hypertension: the nordic diltiazem (NORDIL) study. Lancet 356: 359-365
8. Hansson L, Lindholm LH, Ekbom T et al. (1999) Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity the Swedish Trial in old patients with hypertension-2 study. Lancet 354: 1751-1756
9. Hansson L, Lindholm LH, Niskanen L et al. for the Captopril Prevention Project (CAPP) Study Group (1999) Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPP) randomised trial. Lancet 353: 611-616
10. Hansson L, Zanchetti A, Carruthers SG et al. for the HOT Study Group (1998) Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. Lancet 351: 1755-1762
11. Hypertension Detection And Follow-Up Program Cooperative Group (1979) Five-year findings of the hypertension detection and follow-up program. I. Reduction in mortality of persons with high blood pressure, including mild hypertension. JAMA 242: 2562-2571
12. Hypertension-Stroke Cooperative Study Group (1974) Effect of antihypertensive treatment on stroke recurrence. JAMA 229: 409-418
13. Jorgensen HS, Nakayama H, Christensen HR, Raaschou HO, Kampmann JP, Olsen TS (2002) Blood pressure in acute stroke. The Copenhagen stroke study. Cerebrovasc Dis 13: 204-209
14. Jorgensen HS, Nakayama H, Raaschou HO, Olsen TS (1994) Effect of blood pressure and diabetes on stroke in progression. Lancet 344: 156-159
15. Leonardi-Bee J, Bath P, Phillips S, Sandercock P, IST Collaborative Group (2002) Blood pressure and clinical outcomes in the International Stroke Trial. Stroke 33: 1315-1320
16. MacMahon S, Peto R, Cutler J et al. (1990) Blood pressure, stroke and coronary heart disease. Part 1, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet 335: 765-774
17. Medical Research Council Working Party (1985) MRC trial of treatment of mild hypertension: principal results. BMJ 291: 97-104
18. PATS Collaborative Group (1995) Post-stroke antihypertensive treatment study. Chin Med J 108: 710-717
19. Progress Collaborative Group (2001) Randomised trial ofa perindopril-based blood-pressure lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack. Lancet 358: 1033-1041
20. Rodgers A, MacMahon S, Gamble G, Slattery J, Sandercock P, Warlow C (1996) Blood pressure and risk of stroke in patients with cerebrovascular disease. BMJ 313: 147
21. Schellinger PD, Steiner T (1998) Notfall-und Intensivbe-handlung nach Schlaganfall. Nervenarzt 69: 530-539
22. Schrader J, Lüders S, Kulschewski A et al. on behalf of the ACCESS Study Group (2003) Evaluation ofacute candesartan cilexetil therapy in stroke survivors. Stroke 34: in press
23. SHEP Cooperative Research Group (1991) Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. JAMA 265: 3255-3264
24. Staessen JA, Fagard R, Thijs L et al. for the Systolic Hypertension in Europe (Syst-Eur) Trial Investigators (1997) Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. Lancet 350: 757-764
25. Staessen JA, Gasowski J, Wang JG et al. (2000) Risks of untreated and treated isolated systolic hypertension in the elderly: meta-analysis of outcome trials. Lancet 355: 865-872
26. Staessen JA, Thijs L, O'Brien ET et al. (2002) Ambulatory pulse pressure as predictor of outcome in older patients with hypertension. Am J Hypertens 15: 835-843
27. Stratton IM, Adler AI, Neil HAW et al. on behalf of the UK Prospective Diabetes Study Group (2000) Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPD5 35): prospective observational study. BJM 321: 405-412
28. The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group (2000) Major cardiovascular events in hypertensive patients randomized to doxazosin versus chlorthalidone. The antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). JAMA 283: 1967-1975
29. The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group (2002) Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic. The antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). JAMA 288: 2981-2997
30. The INDANA Project Collaborators (1997) Effect of antihypertensive treatment in patients having already suffered from stroke gathering the evidence. Stroke 28: 2557-2562
31. UK-TIA Study Group (1991) The United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: final results. J Neurol Neurosurg Psychiatr 54: 1044-1054
32. Wahlgren NG, MacMabon DG, De Keyser J, Indredavik B, Ryman T (1994) Intravenous Nimodipine West European Stroke Trial (INWEST) of nimodipine in the treatment of acute ischaemic stroke. Cerebrovasc Dis 4: 204-210
33. Wing LHW, Reid CM, Ryan P et al. for the Second Australian National Blood Pressure Study Group (2003) A comparison of outcomes with angiotensin-converting-enzyme inhibitors and diuretics for hypertension in the elderly. N Engl J Med 348: 583-592